Ducommun vs Rocket Lab
Ducommun reported revenue of $825 million in fiscal 2025, 1.4 times Rocket Lab's $602 million in fiscal 2025. Ducommun's revenue grew 4.9% in its latest year, and Rocket Lab's grew 38.0%. Ducommun had an operating margin of -4.3%, against -38.0% at Rocket Lab. Free cash flow was −$49 million at Ducommun and −$322 million at Rocket Lab.
Side by side
| Ducommun | Rocket Lab | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $825M | $602M |
| Revenue growth | 4.9% | 38.0% |
| Revenue growth a year, last 5 years | 5.6% | 76.4% |
| Gross margin | 26.9% | 34.4% |
| Operating margin | −4.3% | −38.0% |
| Net margin | −4.5% | −32.9% |
| Free cash flow | −$49M | −$322M |
| Free cash flow margin | −5.9% | −53.5% |
| Return on capital | −3.1% | −30.2% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | −0.5% | 7.0% |
| Last close | $139.21 | $50.99 |
| P/E at the last close | 40.5× | — |
| Insider trades, last 12 months | sold $7.6 million | sold $673.4 million |
| Piotroski F-score | 5 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
DucommunRocket Lab
Operating margin
Percent of revenue
DucommunRocket Lab
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
DucommunRocket Lab
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Ducommun and Rocket Lab pages.